Navigation Links
GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
Date:12/17/2008

autoimmune and inflammatory diseases with its first-in-class oligonucleotide-based endosomal TLR inhibitors, called immunoregulatory sequences (IRS). Dynavax's lead inhibitor drug candidate, DV1079, is a bifunctional inhibitor of TLR7 and TLR9, and is expected to enter clinical development in the fourth quarter of 2009.

"We are committed to using our expertise, in collaboration with Dynavax, to research and develop new therapeutics that can improve the lives of patients with conditions like systemic lupus erythematosus, psoriasis and rheumatoid arthritis," commented Jose Carlos Gutierrez-Ramos, Ph.D., Senior Vice President and Head of the Immuno-Inflammation Centre of Excellence for Drug Discovery at GSK. "Dynavax is a recognized pioneer in the scientific community for its innovation of endosomal TLR inhibitors which prevent immune signaling in autoimmune and inflammatory diseases."

Dynavax Conference Call

Dynavax will webcast a conference call today at 9:00 a.m. ET (6:00 a.m. PT) to discuss this alliance. The live and archived webcast can be accessed by visiting the investor relations section of the Company's Web site at http://investors.dynavax.com/events.cfm.

About TLR Inhibitors

Dynavax's endosomal TLR inhibitors are a novel class of oligonucleotides, called immunoregulatory sequences (IRS), that specifically inhibit the TLR-induced inflammatory response associated with autoimmune and inflammatory diseases. Preclinical data from animal model studies show Dynavax's TLR inhibitors block IFN-alpha and also reduce symptoms in multiple autoimmune diseases models, such as lupus, inflammatory skin disorders, and rheumatoid arthritis.

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops a diversified, well-fund
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
2. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
3. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
4. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
5. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
6. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
7. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
8. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
9. GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
10. IADR and GlaxoSmithKline Consumer Healthcare announce winners
11. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance :  – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases – 
(Date:9/2/2014)... 03, 2014 Everyone of a certain age ... easy ways to help minimize them and improve skin quality. ... skin needs to boost collagen levels, which diminish with age ... Skin also needs to be well hydrated, as it tends ... sun and good diet that nourishes skin, two peptides are ...
(Date:9/2/2014)... Illinois (PRWEB) September 02, 2014 ... Chief Executive Officer and Chief Information Officer Strategy ... Carlton Chicago. , Becker's Hospital Review Chief Executive ... together hospital and health system Chief Executive Officers, ... hospital and health system executives through high-quality ...
(Date:9/2/2014)... iFitDress.com, a famous online supplier of wedding dresses and ... 2014 seashell wedding dresses . Additionally, these elegant ... proportion of them are priced under $190. , All ... by the most skilled workers. Along with seashell wedding ... wedding gowns, white halter wedding gowns, regency evening outfits, ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The exciting ... respectively, top-industry professionals Carey Lewis and Bob ... auditioning, seeking those who have the desire to illuminate ... a callback, performers could be invited to join the ... , Charlotte, NC – Saturday, Sept. 6, Charlotte Convention ...
(Date:9/2/2014)... 2014 The use of Xarelto (known ... growing at a rapid pace, even as Xarelto ... around the U.S., Bernstein Liebhard LLP reports. According to ... within a year of its 2011 launch, patients were ... a blood thinner that has been in use for ...
Breaking Medicine News(10 mins):Health News:2 Natural Ways to Relax and Reduce Wrinkles From Sublime Beauty® 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Discounted Seashell Wedding Dresses Currently Provided By iFitDress.com 2Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4
... HealthDay Reporter , MONDAY, Feb. 7 (HealthDay News) -- ... may be less likely to develop a tough-to-treat brain ... It,s not clear how this knowledge might improve prevention ... said the findings pave the way for further research. ...
... Feb. 7 (HealthDay News) -- The number of Americans ... economy, statistics released Monday suggest. Last year, there ... country, up five percent from 2009, the American Society ... cosmetic surgical procedures and 11.6 cosmetic minimally-invasive procedures. The ...
... State for Research and Emilio Botn, president of ... Finantial City (located in Boadilla del Monte) the ... included in PESA (Progression of Early Subclinical Atherosclerosis) ... Center for Cardiovascular Research (CNIC) and Grupo Santander ...
... radiation from cardiac imaging and other procedures after a ... cancer, found a new study published in CMAJ ... only) http://www.cmaj.ca/embargo/cmaj100463.pdf . The use of procedures ... angiography and nuclear scans, is increasing which has led ...
... Geneva, Switzerland. Following the publication of several media reports ... grants financed by the Global Fund to Fight AIDS, ... all donors and governments to continue their funding. ... instrument which attracts, manages and disburses resources to prevent ...
... diseases. Gene therapy direct replacement of mutant genes by ... defects. Now a research team based at the Medical Center ... Carsten Rudolph, has taken a new approach that avoids DNA ... modification of mRNAs (the metabolically active molecules derived from genomic ...
Cached Medicine News:Health News:Allergies Linked to Lower Brain Cancer Rate in Study 2Health News:Allergies Linked to Lower Brain Cancer Rate in Study 3Health News:As Economy Picks Up, So Do Number of Nips & Tucks 2Health News:CNIC and Grupo Santander present a new venue for imaging tests included in PESA study 2Health News:CNIC and Grupo Santander present a new venue for imaging tests included in PESA study 3Health News:Risk of cancer increases with exposure to low-dose radiation 2Health News:Media reports ignore that Global Fund resources deliver tremendous results in the fight against AIDS 2Health News:Save messengers -- modified mRNAs open up new therapeutic possibilities 2
(Date:9/2/2014)... , Sept. 2, 2014   Santa Clara dentist ... a special promotion for Invisalign. Invisalign is an orthodontic ... wires. It is often the orthodontic treatment of choice ... and aesthetics of it. For a limited time, patients ... significant savings from the usual cost. This offer cannot ...
(Date:9/2/2014)... 2, 2014 ... bij het ESC CONGRESS 2014 geven inzicht ... risico op beroerte in de dagelijkse klinische ... bijna 12.500 patiënten ingeschreven in de Global ... een innovatief, onafhankelijk initiatief op het gebied ...
(Date:9/2/2014)... According to the new market research report ... Material (Metal, Glass, Plastic), by Application [GC, LC (HPLC, ... by MarketsandMarkets, the Chiral Chromatography Columns Market was valued ... at a CAGR of 5.2% from 2013 to reach ... market data tables and 15 figures spread through 135 ...
Breaking Medicine Technology:Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 2Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 3Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 4Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 5Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 6Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 7Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 8Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 9Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 10Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4
... PHOENIX, April 5, 2011 Express Scripts contributed more ... to an economic analysis of the company,s data by ... The economic impact study, presented today to ... company,s operations support 2,665 direct and indirect jobs in ...
... its first quarter 2011 earnings release (expected to be issued ... CVD ) is pleased to invite you to ... broadcast live over the Internet on Thursday, May 5, 2011 ... Webcast and Slide PresentationWhen: , Thursday, May 5, 2011, 9:00 ...
Cached Medicine Technology:Express Scripts Injects $226 Million Into Arizona Economy, Study Finds 2
... Endotracheal Tube Kits (silicone) Magill, ... includes a SidePort™ AutoControl™ airway connector, ... mm ISO connector., ,The wire ... helping to ensure an open airway., ...
... Portex® Blue Line® uncuffed endotracheal ... or Murphy styles, in standard ... Line® adult and pediatric uncuffed ... implant-tested polyvinyl chloride with a ...
Portex® Blue Line® cuffed endotracheal tubes come in a wide selection of sizes, each with a standard 15 mm ISO connector., ,Portex® Blue Line® endotracheal tubes are recognized world...
... Rusch Safety Clear Plus™ Uncuffed Endotracheal Tube w. ... Sterile, Single use. A quality Rusch endotracheal tube ... use saving you time and storage space. The ... smooth withdrawal. It is designed with a soft ...
Medicine Products: